Lisa Heine

Natus Medical, Inc. engages in providing healthcare solutions. It also focuses on the diagnosis and treatment of central nervous and sensory system disorders. The company was founded by Maurizio Liverani, John Robert Camber Porter, William Jr. New, Brian Prinn and William W. Moore on May 26, 1987 and is headquartered in Middleton, WI.

Mitralign, Inc. operates as a valve repair company that engages in transcatheter annuloplasty system designed to treat both functional tricuspid regurgitation and mitral regurgitation. The Mitralign Percutaneous Annuloplasty System, MPAS, is intended for the treatment of symptomatic functional mitral regurgitation for annular reduction through tissue plication. The company was founded by Paul A. Spence and Richard P. Geoffrion in 2003 and is headquartered in Tewksbury, MA.

Vascular Therapies, Inc. operates as a biopharmaceutical firm that develops and commercialize treatments of patients requiring an AV fistula for dialysis. It provides plan on the hemodialysis vascular access indication. The company was founded by Sriram Iyer in 2001 and is headquartered in Cresskill, NJ.

Covidien Unlimited Co. engages in the development, manufacture, and sale of healthcare products for use in clinical and home settings. It operates through Medical Devices and U.S. Medical Supplies segments. The Medical Devices segment involves in the distribution of surgical solutions, peripheral vascular and neurovascular therapies, patient monitoring products, and airway and ventilation products. The U.S. Medical Supplies segment includes marketing of nursing care, medical surgical, SharpSafety brand, and original equipment manufacturer (OEM) products. The company was founded in 1967 and is headquartered in Dublin, Ireland.

Precardia, Inc. is an American medical technology company that aims to improve the quality of life for patients suffering from acute decompensated heart failure (ADHF). The company's proprietary balloon catheter and pump controller technology is designed to address ADHF through cardio-renal volume unloading via intermittent superior vena cava (SVC) occlusion. Precardia's system is an investigational device and is limited by federal law to investigational use. The company was founded and incubated by MD Start and is headquartered in the USA. The company was founded by Tim Lenihan. Precardia was acquired by ABIOMED, Inc. on June 01, 2021 for $82.80 million.